MENU
+Compare
BIAF
Stock ticker: NASDAQ
AS OF
Oct 17 closing price
Price
$2.94
Change
-$0.47 (-13.78%)
Capitalization
13.23M

BIAF bioAffinity Technologies Inc Forecast, Technical & Fundamental Analysis

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment... Show more

BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BIAF with price predictions
Oct 17, 2025

BIAF in downward trend: price dove below 50-day moving average on September 16, 2025

BIAF moved below its 50-day moving average on September 16, 2025 date and that indicates a change from an upward trend to a downward trend. In of 31 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIAF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BIAF broke above its upper Bollinger Band on October 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BIAF entered a downward trend on October 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BIAF's RSI Indicator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 45 cases where BIAF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 16, 2025. You may want to consider a long position or call options on BIAF as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BIAF just turned positive on October 13, 2025. Looking at past instances where BIAF's MACD turned positive, the stock continued to rise in of 29 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.608) is normal, around the industry mean (12.123). P/E Ratio (0.000) is within average values for comparable stocks, (140.368). BIAF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.782). BIAF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.215) is also within normal values, averaging (9.607).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BIAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BIAF is expected to report earnings to fall 44.59% to -9 cents per share on November 12

bioAffinity Technologies Inc BIAF Stock Earnings Reports
Q3'25
Est.
$-0.09
Q2'25
Missed
by $0.07
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.01
The last earnings report on August 14 showed earnings per share of -17 cents, missing the estimate of -10 cents. With 702.62K shares outstanding, the current market capitalization sits at 13.23M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
22211 W Interstate 10
Phone
+1 210 698-5334
Employees
75
Web
https://www.bioaffinitytech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FOX51.890.62
+1.21%
Fox Corp
IMNN5.090.03
+0.59%
Imunon Inc
TR43.50-0.18
-0.41%
Tootsie Roll Industries Inc
SCHL28.42-0.14
-0.49%
Scholastic Corp
MRCC6.78-0.22
-3.14%
Monroe Capital Corp

BIAF and Stocks

Correlation & Price change

A.I.dvisor tells us that BIAF and SNWV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIAF and SNWV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIAF
1D Price
Change %
BIAF100%
-13.78%
SNWV - BIAF
32%
Poorly correlated
-3.06%
HSCS - BIAF
29%
Poorly correlated
-2.20%
RDNT - BIAF
26%
Poorly correlated
-0.59%
AORT - BIAF
22%
Poorly correlated
+1.30%
TCMD - BIAF
21%
Poorly correlated
-1.09%
More